Skip to main content
Clinical Trials/TCTR20220516004
TCTR20220516004
Completed
Phase 4

The study to evaluate the efficacy and safety of using Platelet-rich plasma for treating melasma in Thailand

Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand0 sites25 target enrollmentMay 16, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Healthy human volunteers
Sponsor
Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand
Enrollment
25
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2022
End Date
August 1, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand

Eligibility Criteria

Inclusion Criteria

  • 1\. Epidermal or mixed types melasma2\. Thais 3\. Healthy

Exclusion Criteria

  • 1\. pregnant or lactating woman 2\. Having severe acnes 3\. Having the skin disease around the treated area 4\. Using an energy\-based device or other interventions around treated area 6 months prior

Outcomes

Primary Outcomes

Not specified

Similar Trials